EP1695704A1 - Utilisation de derives d`aryl (ou heteroaryl) azolylcarbinol pour le traitement des la fibromylagie - Google Patents
Utilisation de derives d`aryl (ou heteroaryl) azolylcarbinol pour le traitement des la fibromylagie Download PDFInfo
- Publication number
- EP1695704A1 EP1695704A1 EP05004328A EP05004328A EP1695704A1 EP 1695704 A1 EP1695704 A1 EP 1695704A1 EP 05004328 A EP05004328 A EP 05004328A EP 05004328 A EP05004328 A EP 05004328A EP 1695704 A1 EP1695704 A1 EP 1695704A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- methyl
- imidazole
- dimethylamino
- radical
- benzyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- MJDTUHIEWHBAJJ-UHFFFAOYSA-N CC1=NCC2N1CCCN(C)C2 Chemical compound CC1=NCC2N1CCCN(C)C2 MJDTUHIEWHBAJJ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Definitions
- CFS Crohn's disease
- CFS chronic fatigue syndrome
- a debilitating and complex disorder characterized by profound fatigue that is not improved by bed rest and that may be worsened by physical or mental activity Persons with CFS most often function at a substantially lower level of activity than they were capable of before the onset of illness.
- patients report various nonspecific symptoms, including weakness, muscle pain. impaired memory and/or mental concentration, insomnia, and post-exertional fatigue lasting more than 24 hours.
- CFS can persist for years. The cause or causes of CFS have not been identified and no specific diagnostic tests are available.” Still therefore, there is a great need for a compound to treat Accordingly there is an urgent need for an effective cure of fibromyalgia and chronic fatigue syndrome.
- a preferred use according to the invention is characterized in that the medicament is for oral administration, especially in form of a tablet or capsule.
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05004328A EP1695704A1 (fr) | 2005-02-28 | 2005-02-28 | Utilisation de derives d`aryl (ou heteroaryl) azolylcarbinol pour le traitement des la fibromylagie |
ES200500793A ES2286920B1 (es) | 2005-02-15 | 2005-04-01 | Derivados de aril (o heteroaril)azolilcarbinoles para el tratamiento de la fibromialgia. |
PCT/EP2006/001239 WO2006087147A2 (fr) | 2005-02-15 | 2006-02-10 | Derives d'aryl (ou heteroaryl) azolylcarbinols destines au traitement de la fibromyalgie |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05004328A EP1695704A1 (fr) | 2005-02-28 | 2005-02-28 | Utilisation de derives d`aryl (ou heteroaryl) azolylcarbinol pour le traitement des la fibromylagie |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1695704A1 true EP1695704A1 (fr) | 2006-08-30 |
Family
ID=34933977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05004328A Withdrawn EP1695704A1 (fr) | 2005-02-15 | 2005-02-28 | Utilisation de derives d`aryl (ou heteroaryl) azolylcarbinol pour le traitement des la fibromylagie |
Country Status (1)
Country | Link |
---|---|
EP (1) | EP1695704A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007017127A2 (fr) * | 2005-07-29 | 2007-02-15 | Laboratorios Del Dr. Esteve, S.A | Forme dosifiee a liberation controlee de composes pyrazole |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0289380A1 (fr) * | 1987-04-10 | 1988-11-02 | Laboratorios Del Dr. Esteve, S.A. | Dérivés d'aryl-hétéroaryl carbinols avec activité analgésique |
US6518295B1 (en) * | 1998-08-07 | 2003-02-11 | Laboratorios Del Dr. Esteve, S.A. | Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance P |
WO2005011684A1 (fr) * | 2003-07-31 | 2005-02-10 | Grünenthal GmbH | Medicaments contenant des derives d'arylazolylcarbinols ou d'heteroarylazolylcarbinols |
-
2005
- 2005-02-28 EP EP05004328A patent/EP1695704A1/fr not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0289380A1 (fr) * | 1987-04-10 | 1988-11-02 | Laboratorios Del Dr. Esteve, S.A. | Dérivés d'aryl-hétéroaryl carbinols avec activité analgésique |
US6518295B1 (en) * | 1998-08-07 | 2003-02-11 | Laboratorios Del Dr. Esteve, S.A. | Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance P |
WO2005011684A1 (fr) * | 2003-07-31 | 2005-02-10 | Grünenthal GmbH | Medicaments contenant des derives d'arylazolylcarbinols ou d'heteroarylazolylcarbinols |
Non-Patent Citations (5)
Title |
---|
FARRE A J ET AL: "CIZOLIRTINE CITRATE", DRUGS OF THE FUTURE, BARCELONA, ES, vol. 27, no. 8, 1 August 2002 (2002-08-01), pages 721 - 732, XP009043624, ISSN: 0377-8282 * |
GOLDENBERG D L: "FIBROMYALGIA, CHRONIC FATIGUE SYNDROME, AND MYOFASCIAL PAIN SYNDROME", CURRENT OPINION IN RHEUMATOLOGY, CURRENT SCIENCE, LONDON, GB, vol. 6, no. 2, 1994, pages 223 - 233, XP001022309, ISSN: 1040-8711 * |
KLIMAS N: "Pathogenesis of chronic fatiguesyndrome and fibromyalgia", GROWTH HORMONE AND IGF RESEARCH, CHURCHILL LIVINGSTONE, LONDON,, GB, vol. 8, April 1998 (1998-04-01), pages 123 - 126, XP004849760, ISSN: 1096-6374 * |
MONCK N: "CIZOLIRTINE LABORATORIOS DR ESTEVE", CURRENT OPINION IN INVESTIGATIONAL DRUGS, CURRENT DRUGS, LONDON, GB, vol. 2, no. 9, 2001, pages 1269 - 1272, XP009043627, ISSN: 0967-8298 * |
SHEMBALKAR P ET AL: "CIZOLIRTINE CITRATE (E-4018) IN THE TREATMENT OF CHRONIC NEUROPATHIC PAIN", CURRENT MEDICAL RESEARCH AND OPINION, HANTS, GB, vol. 17, no. 4, 2001, pages 262 - 266, XP009043626 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007017127A2 (fr) * | 2005-07-29 | 2007-02-15 | Laboratorios Del Dr. Esteve, S.A | Forme dosifiee a liberation controlee de composes pyrazole |
WO2007017127A3 (fr) * | 2005-07-29 | 2007-04-19 | Esteve Labor Dr | Forme dosifiee a liberation controlee de composes pyrazole |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1781272B1 (fr) | Utilisation de composes actifs sur le recepteur sigma pour le traitement de l'allodynie mecanique | |
US20080200693A1 (en) | Derivatives of Aryl (or Heteroaryl) Azolylcarbinols (in Particular Cizolirtin Citrate) for the Treatment of Opioid Addiction | |
US20070088024A1 (en) | Active substance combination comprising a carbinol combined to at least an NSAID | |
JP2002522359A (ja) | 過剰のサブスタンスpによって仲介される障害の処置用医薬の製造におけるアリール(またはヘテロアリール)アゾリルカルビノール誘導体の使用 | |
JP4511176B2 (ja) | 尿失禁の治療のための、ムスカリン−アンタゴニストと選択されたオピオイドのコンビネーション | |
WO2007009701A2 (fr) | Utilisation de composes pyrazoliniques substitues pour traiter des facteurs de risque cardiovasculaires imputables a des troubles du metabolisme ou de l'alimentation | |
JP2007531784A (ja) | 活性物質組合せ物 | |
ES2304659T3 (es) | Utilizacion de (1rs,3rs,6rs)-6-dimetilaminometil-1-(3-metoxifenil)-1,3-ciclohexanodiol para el tratamiento del dolor inflamatorio. | |
EP1743637A1 (fr) | Utilisation des derivés du pyrazole seuls ou en combinaison pour le traitement du syndrome métabolique | |
WO2006027226A1 (fr) | Derives d'aryl(ou heteroaryl) azolylcarbinols pour le traitement de douleur neuropathique centrale | |
US20060040924A1 (en) | Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic | |
US20180235909A1 (en) | Use of 1-phenyl-3-dimethylaminopropane Compounds for Treating Rheumatoid Pain | |
WO2006087147A2 (fr) | Derives d'aryl (ou heteroaryl) azolylcarbinols destines au traitement de la fibromyalgie | |
US20060194860A1 (en) | Pharmaceutical compositions containing aryl or heteroaryl azolylcarbinol compounds | |
EP1695704A1 (fr) | Utilisation de derives d`aryl (ou heteroaryl) azolylcarbinol pour le traitement des la fibromylagie | |
WO2006027223A1 (fr) | Utilisation de derives de piperazine et d'analogues pour la fabrication d'un medicament servant a prevenir et/ou a traiter des troubles de l'ingestion d'aliments | |
EP1690537A1 (fr) | Utilisation de dérivés d'aryl(ou heteroaryl)azolylcarbinol pour le traitment de la fibromyalgie | |
ES2286920B1 (es) | Derivados de aril (o heteroaril)azolilcarbinoles para el tratamiento de la fibromialgia. | |
JP2007531785A (ja) | 活性物質組合せ物 | |
EP1784178A1 (fr) | Aryl (ou heteroaryl) azolylcarbinols | |
JP4271142B2 (ja) | 1−ジメチルアミノ−3−(3−メトキシ−フェニル)−2−メチル−ペンタン−3−オール及び3−(3−ジメチルアミノ−1−エチル−1−ヒドロキシ−2−メチル−プロピル)−フェノールの有効物質塩及びエステル | |
US20070021485A1 (en) | Aryl (or heteroaryl) azolylcarbinols | |
WO2007009700A2 (fr) | Utilisation de composes pyrazoliniques substitues pour le traitement de parametres des lipides du syndrome metabolique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR LV MK YU |
|
AKX | Designation fees paid | ||
REG | Reference to a national code |
Ref country code: DE Ref legal event code: 8566 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20070301 |